rss
Br J Ophthalmol 2005;89:437-443 doi:10.1136/bjo.2004.051250
  • Clinical science
    • Extended reports

Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green

  1. J Hillenkamp1,
  2. P Saikia1,
  3. F Gora1,
  4. H G Sachs1,
  5. C P Lohmann1,
  6. J Roider2,
  7. W Bäumler3,
  8. V-P Gabel1
  1. 1Department of Ophthalmology, University of Regensburg, Germany
  2. 2Department of Ophthalmology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
  3. 3Department of Dermatology, University of Regensburg, Germany
  1. Correspondence to: Dr Jost Hillenkamp Eye Hospital, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany; hillenkahotmail.com
  • Accepted 1 August 2004

Abstract

Aim: To investigate macular function and morphology after surgical removal of idiopathic epiretinal membrane (IEM) with and without assistance of indocyanine green (ICG).

Methods: A retrospective study as a consecutive case series, of 39 patients with IEM. 39 patients, 23 female, 16 male, mean age 67 years, underwent standard three port pars plana vitrectomy with removal of epiretinal membrane. Two groups of patients were consecutively operated: in 20 patients ICG 0.1% in glucose 5% was used to stain the epiretinal membrane. 19 patients underwent the identical procedure but without use of ICG. Postoperative follow up was 1–92 months (mean 15.5 months). Functional outcome was assessed with subjective improvement, best corrected visual acuity (BCVA), Amsler grid test, 10° and 30° automated perimetry (Heidelberg visual field analyser) (HFA), and Goldmann kinetic perimetry. Macular morphology was assessed with stereoscopic biomicroscopy and optical coherence tomography (OCT). The main outcome measures were macular function as determined by BCVA, presence of visual field defects, and metamorphopsia as determined by Amsler grid test, macular morphology as determined by slit lamp biomicroscopy, and OCT.

Results: BCVA improved in 28 patients, remained unchanged in eight patients, and decreased in three patients. Improvement of BCVA was statistically significant in both groups (p = 0.003). Mean BCVA in patients operated with ICG improved from 0.33 preoperatively to 0.53 postoperatively. Mean BCVA in patients operated without ICG improved from 0.32 preoperatively to 0.54 postoperatively. Reduction of macular oedema as measured by OCT was statistically significant in both groups (p<0.01). There was no statistically significant difference in postoperative BCVA, macular oedema as measured by OCT, postoperative Amsler grid test, and subjective improvement between the two groups. The incidence of residual or recurrent epiretinal membrane was greater in the group operated without ICG (p = 0.014). Visual field defects were detected in one patient operated with ICG and in three patients operated without ICG.

Conclusions: Removal of epiretinal tissue with or without assistance of ICG improved visual function and reduced macular oedema in most patients. Adverse effects clearly attributable to the use of ICG were not observed but further investigation is warranted.

Footnotes

  • Competing interests: None of the authors has a financial interest in indocyanine green.

  • Ethical approval: Approval was obtained from the ethics committee of the University of Regensburg.

  • Presented in part at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, USA, 25–29 April 2004.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.